论文部分内容阅读
就当前中国最大的社会特征——人口老龄化而言,人口老龄化的加剧将给医药行业带来巨大的投资机会。老年人身体条件较差,自然需要更多的医疗保健服务,其中医药在医疗行业中所占份额最大,影响最大,医药行业在制药、器械等多个领域都具备成熟的投资环境,政策的鼓励以及医药行业的高速发展都注定了人口老龄化前提下医药行业具有广阔的投资机遇,其中在化学制剂、生物制药、医疗器械、原料药、中成药等领域投资机会最佳。
In terms of the current aging population in China, the largest social feature in China, the aging population will bring tremendous investment opportunities to the pharmaceutical industry. Elderly physical condition is poor, naturally need more health care services, of which medicine in the medical industry accounted for the largest share, the greatest impact, the pharmaceutical industry in the pharmaceutical, equipment and other fields have a mature investment environment, policy encouragement As well as the rapid development of the pharmaceutical industry are doomed to the aging population under the premise of the pharmaceutical industry has a wide range of investment opportunities, including chemicals, biopharmaceuticals, medical devices, APIs, proprietary Chinese medicine and other fields the best investment opportunities.